A new trading day began on Friday, with Sensei Biotherapeutics Inc (NASDAQ: SNSE) stock price down -7.95% from the previous day of trading, before settling in for the closing price of $10.56. SNSE’s price has ranged from $5.00 to $18.35 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -11.38%. Meanwhile, its annual earnings per share averaged 24.29%. With a float of $0.83 million, this company’s outstanding shares have now reached $1.26 million.
Sensei Biotherapeutics Inc (SNSE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Sensei Biotherapeutics Inc is 34.19%, while institutional ownership is 3.95%. The most recent insider transaction that took place on Dec 04 ’25, was worth 50,901. Before that another transaction happened on Dec 04 ’25, when Company’s 10% Owner proposed sale 21,222 for $8.71, making the entire transaction worth $184,843.
Sensei Biotherapeutics Inc (SNSE) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -5.46 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months).
According to the Wall Street analysts, stocks earnings will be around 24.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.69% during the next five years compared to -11.38% drop over the previous five years of trading.
Sensei Biotherapeutics Inc (NASDAQ: SNSE) Trading Performance Indicators
Here are Sensei Biotherapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -21.31, a number that is poised to hit -4.81 in the next quarter and is forecasted to reach -15.05 in one year’s time.
Technical Analysis of Sensei Biotherapeutics Inc (SNSE)
Compared to the last year’s volume of 62991.0, its volume of 0.37 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 57.43%.
During the past 100 days, Sensei Biotherapeutics Inc’s (SNSE) raw stochastic average was set at 28.23%, which indicates a significant decrease from 39.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.35 in the past 14 days, which was higher than the 1.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.92, while its 200-day Moving Average is $8.44. Nevertheless, the first resistance level for the watch stands at $12.84 in the near term. At $15.95, the stock is likely to face the second major resistance level. The third major resistance level sits at $18.65. If the price goes on to break the first support level at $7.03, it is likely to go to the next support level at $4.33. Should the price break the second support level, the third support level stands at $1.22.
Sensei Biotherapeutics Inc (NASDAQ: SNSE) Key Stats
With a market capitalization of 12.26 million, the company has a total of 1,261K Shares Outstanding. Currently, annual sales are 0 K while annual income is -30,160 K. The company’s previous quarter sales were 0 K while its latest quarter income was -4,570 K.
